APO Research
Talk to an analyst

APO RESEARCH · REPORT

NADPH Oxidase 4

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NADPH Oxidase 4 Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchNADPH Oxidase 4 Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal NADPH Oxidase 4 Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal NADPH Oxidase 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NADPH Oxidase 4 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal NADPH Oxidase 4 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global NADPH Oxidase 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NADPH Oxidase 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NADPH Oxidase 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NADPH Oxidase 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NADPH Oxidase 4 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NADPH Oxidase 4 market include Bioasis Technologies Inc, GenKyoTex SA and Glucox Biotech AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NADPH Oxidase 4 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NADPH Oxidase 4 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NADPH Oxidase 4 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NADPH Oxidase 4 market size, projected growth trends, production technologies, key applications, and end-use industries.

NADPH Oxidase 4 Segment by Company

Bioasis Technologies Inc

GenKyoTex SA

Glucox Biotech AB

NADPH Oxidase 4 Segment by Type

MTfp-siRNA

GKT-831

GKT-136901

Others

NADPH Oxidase 4 Segment by Application

Liver Fibrosis

Ischemic Stroke

Kidney Fibrosis

Kidney Disease

Others

NADPH Oxidase 4 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NADPH Oxidase 4 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions NADPH Oxidase 4 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NADPH Oxidase 4 significant trends, drivers, influence factors in global and regions.

6. To analyze NADPH Oxidase 4 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NADPH Oxidase 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NADPH Oxidase 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NADPH Oxidase 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NADPH Oxidase 4 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NADPH Oxidase 4 industry.

Chapter 3: Detailed analysis of NADPH Oxidase 4 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of NADPH Oxidase 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of NADPH Oxidase 4 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NADPH Oxidase 4 Industry Trends Table 2. NADPH Oxidase 4 Industry Drivers Table 3. NADPH Oxidase 4 Industry Opportunities and Challenges Table 4. NADPH Oxidase 4 Industry Restraints Table 5. Global NADPH Oxidase 4 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NADPH Oxidase 4 Revenue Share by Company (2021-2026) Table 7. Global NADPH Oxidase 4 Sales Volume by Company (k units) & (2021-2026) Table 8. Global NADPH Oxidase 4 Sales Volume Share by Company (2021-2026) Table 9. Global NADPH Oxidase 4 Average Price (US$/unit) of Company (2021-2026) Table 10. Global NADPH Oxidase 4 Company Ranking, (2024-2026) & (USD Million) Table 11. Global NADPH Oxidase 4 Key Company Manufacturing Base & Headquarters Table 12. Global NADPH Oxidase 4 Company, Product Type & Application Table 13. Global NADPH Oxidase 4 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global NADPH Oxidase 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of MTfp-siRNA Table 18. Significant Companies of GKT-831 Table 19. Significant Companies of GKT-136901 Table 20. Significant Companies of Others Table 21. Global NADPH Oxidase 4 Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global NADPH Oxidase 4 Sales Volume by Type (2021-2026) & (k units) Table 23. Global NADPH Oxidase 4 Sales Volume by Type (2027-2032) & (k units) Table 24. Global NADPH Oxidase 4 Sales Volume Share by Type (2021-2026) Table 25. Global NADPH Oxidase 4 Sales Volume Share by Type (2027-2032) Table 26. Global NADPH Oxidase 4 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global NADPH Oxidase 4 Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global NADPH Oxidase 4 Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global NADPH Oxidase 4 Sales Value Share by Type (2021-2026) Table 30. Global NADPH Oxidase 4 Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Liver Fibrosis Table 32. Significant Companies of Ischemic Stroke Table 33. Significant Companies of Kidney Fibrosis Table 34. Significant Companies of Kidney Disease Table 35. Significant Companies of Others Table 36. Global NADPH Oxidase 4 Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global NADPH Oxidase 4 Sales Volume by Application (2021-2026) & (k units) Table 38. Global NADPH Oxidase 4 Sales Volume by Application (2027-2032) & (k units) Table 39. Global NADPH Oxidase 4 Sales Volume Share by Application (2021-2026) Table 40. Global NADPH Oxidase 4 Sales Volume Share by Application (2027-2032) Table 41. Global NADPH Oxidase 4 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global NADPH Oxidase 4 Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global NADPH Oxidase 4 Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global NADPH Oxidase 4 Sales Value Share by Application (2021-2026) Table 45. Global NADPH Oxidase 4 Sales Value Share by Application (2027-2032) Table 46. Global NADPH Oxidase 4 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global NADPH Oxidase 4 Sales by Region (2021-2026) & (k units) Table 48. Global NADPH Oxidase 4 Sales Market Share by Region (2021-2026) Table 49. Global NADPH Oxidase 4 Sales by Region (2027-2032) & (k units) Table 50. Global NADPH Oxidase 4 Sales Market Share by Region (2027-2032) Table 51. Global NADPH Oxidase 4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global NADPH Oxidase 4 Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global NADPH Oxidase 4 Sales Value Share by Region (2021-2026) Table 54. Global NADPH Oxidase 4 Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global NADPH Oxidase 4 Sales Value Share by Region (2027-2032) Table 56. Global NADPH Oxidase 4 Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global NADPH Oxidase 4 Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global NADPH Oxidase 4 Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global NADPH Oxidase 4 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global NADPH Oxidase 4 Sales by Country (2021-2026) & (k units) Table 61. Global NADPH Oxidase 4 Sales Market Share by Country (2021-2026) Table 62. Global NADPH Oxidase 4 Sales by Country (2027-2032) & (k units) Table 63. Global NADPH Oxidase 4 Sales Market Share by Country (2027-2032) Table 64. Global NADPH Oxidase 4 Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global NADPH Oxidase 4 Sales Value Market Share by Country (2021-2026) Table 66. Global NADPH Oxidase 4 Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global NADPH Oxidase 4 Sales Value Market Share by Country (2027-2032) Table 68. Bioasis Technologies Inc Company Information Table 69. Bioasis Technologies Inc Business Overview Table 70. Bioasis Technologies Inc NADPH Oxidase 4 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Bioasis Technologies Inc NADPH Oxidase 4 Product Portfolio Table 72. Bioasis Technologies Inc Recent Development Table 73. GenKyoTex SA Company Information Table 74. GenKyoTex SA Business Overview Table 75. GenKyoTex SA NADPH Oxidase 4 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. GenKyoTex SA NADPH Oxidase 4 Product Portfolio Table 77. GenKyoTex SA Recent Development Table 78. Glucox Biotech AB Company Information Table 79. Glucox Biotech AB Business Overview Table 80. Glucox Biotech AB NADPH Oxidase 4 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Glucox Biotech AB NADPH Oxidase 4 Product Portfolio Table 82. Glucox Biotech AB Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. NADPH Oxidase 4 Distributors List Table 86. NADPH Oxidase 4 Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. NADPH Oxidase 4 Product Image Figure 2. Global NADPH Oxidase 4 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NADPH Oxidase 4 Sales Value (2021-2032) & (US$ Million) Figure 4. Global NADPH Oxidase 4 Sales (2021-2032) & (k units) Figure 5. Global NADPH Oxidase 4 Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global NADPH Oxidase 4 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. MTfp-siRNA Image Figure 10. GKT-831 Image Figure 11. GKT-136901 Image Figure 12. Others Image Figure 13. Global NADPH Oxidase 4 Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global NADPH Oxidase 4 Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global NADPH Oxidase 4 Sales Volume Share by Type (2021-2032) Figure 16. Global NADPH Oxidase 4 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global NADPH Oxidase 4 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global NADPH Oxidase 4 Sales Value Share by Type (2021-2032) Figure 19. Liver Fibrosis Image Figure 20. Ischemic Stroke Image Figure 21. Kidney Fibrosis Image Figure 22. Kidney Disease Image Figure 23. Others Image Figure 24. Global NADPH Oxidase 4 Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global NADPH Oxidase 4 Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global NADPH Oxidase 4 Sales Volume Share by Application (2021-2032) Figure 27. Global NADPH Oxidase 4 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global NADPH Oxidase 4 Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global NADPH Oxidase 4 Sales Value Share by Application (2021-2032) Figure 30. Global NADPH Oxidase 4 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global NADPH Oxidase 4 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global NADPH Oxidase 4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global NADPH Oxidase 4 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America NADPH Oxidase 4 Sales Value (2021-2032) & (US$ Million) Figure 35. North America NADPH Oxidase 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe NADPH Oxidase 4 Sales Value (2021-2032) & (US$ Million) Figure 37. Europe NADPH Oxidase 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific NADPH Oxidase 4 Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific NADPH Oxidase 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America NADPH Oxidase 4 Sales Value (2021-2032) & (US$ Million) Figure 41. South America NADPH Oxidase 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa NADPH Oxidase 4 Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa NADPH Oxidase 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt NADPH Oxidase 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. NADPH Oxidase 4 Value Chain Figure 129. Manufacturing Cost Structure Figure 130. NADPH Oxidase 4 Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • MTfp-siRNA
  • GKT-831
  • GKT-136901
  • Others
Applications
  • Liver Fibrosis
  • Ischemic Stroke
  • Kidney Fibrosis
  • Kidney Disease
  • Others
Companies covered
  • Bioasis Technologies Inc
  • GenKyoTex SA
  • Glucox Biotech AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NADPH Oxidase 4 Sales Value (2021-2032)
  4. 1.2.2 Global NADPH Oxidase 4 Sales Volume (2021-2032)
  5. 1.2.3 Global NADPH Oxidase 4 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 NADPH Oxidase 4 Market Dynamics
  1. 2.1 NADPH Oxidase 4 Industry Trends
  2. 2.2 NADPH Oxidase 4 Industry Drivers
  3. 2.3 NADPH Oxidase 4 Industry Opportunities and Challenges
  4. 2.4 NADPH Oxidase 4 Industry Restraints
3 NADPH Oxidase 4 Market by Company
  1. 3.1 Global NADPH Oxidase 4 Company Revenue Ranking in 2025
  2. 3.2 Global NADPH Oxidase 4 Revenue by Company (2021-2026)
  3. 3.3 Global NADPH Oxidase 4 Sales Volume by Company (2021-2026)
  4. 3.4 Global NADPH Oxidase 4 Average Price by Company (2021-2026)
  5. 3.5 Global NADPH Oxidase 4 Company Ranking (2024-2026)
  6. 3.6 Global NADPH Oxidase 4 Company Manufacturing Base and Headquarters
  7. 3.7 Global NADPH Oxidase 4 Company Product Type and Application
  8. 3.8 Global NADPH Oxidase 4 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global NADPH Oxidase 4 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 NADPH Oxidase 4 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 NADPH Oxidase 4 Market by Type
  1. 4.1 NADPH Oxidase 4 Type Introduction
  2. 4.1.1 MTfp-siRNA
  3. 4.1.2 GKT-831
  4. 4.1.3 GKT-136901
  5. 4.1.4 Others
  6. 4.2 Global NADPH Oxidase 4 Sales Volume by Type
  7. 4.2.1 Global NADPH Oxidase 4 Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global NADPH Oxidase 4 Sales Volume by Type (2021-2032)
  9. 4.2.3 Global NADPH Oxidase 4 Sales Volume Share by Type (2021-2032)
  10. 4.3 Global NADPH Oxidase 4 Sales Value by Type
  11. 4.3.1 Global NADPH Oxidase 4 Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global NADPH Oxidase 4 Sales Value by Type (2021-2032)
  13. 4.3.3 Global NADPH Oxidase 4 Sales Value Share by Type (2021-2032)
5 NADPH Oxidase 4 Market by Application
  1. 5.1 NADPH Oxidase 4 Application Introduction
  2. 5.1.1 Liver Fibrosis
  3. 5.1.2 Ischemic Stroke
  4. 5.1.3 Kidney Fibrosis
  5. 5.1.4 Kidney Disease
  6. 5.1.5 Others
  7. 5.2 Global NADPH Oxidase 4 Sales Volume by Application
  8. 5.2.1 Global NADPH Oxidase 4 Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global NADPH Oxidase 4 Sales Volume by Application (2021-2032)
  10. 5.2.3 Global NADPH Oxidase 4 Sales Volume Share by Application (2021-2032)
  11. 5.3 Global NADPH Oxidase 4 Sales Value by Application
  12. 5.3.1 Global NADPH Oxidase 4 Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global NADPH Oxidase 4 Sales Value by Application (2021-2032)
  14. 5.3.3 Global NADPH Oxidase 4 Sales Value Share by Application (2021-2032)
6 NADPH Oxidase 4 Regional Sales and Value Analysis
  1. 6.1 Global NADPH Oxidase 4 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NADPH Oxidase 4 Sales by Region (2021-2032)
  3. 6.2.1 Global NADPH Oxidase 4 Sales by Region: 2021-2026
  4. 6.2.2 Global NADPH Oxidase 4 Sales by Region (2027-2032)
  5. 6.3 Global NADPH Oxidase 4 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global NADPH Oxidase 4 Sales Value by Region (2021-2032)
  7. 6.4.1 Global NADPH Oxidase 4 Sales Value by Region: 2021-2026
  8. 6.4.2 Global NADPH Oxidase 4 Sales Value by Region (2027-2032)
  9. 6.5 Global NADPH Oxidase 4 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America NADPH Oxidase 4 Sales Value (2021-2032)
  12. 6.6.2 North America NADPH Oxidase 4 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe NADPH Oxidase 4 Sales Value (2021-2032)
  15. 6.7.2 Europe NADPH Oxidase 4 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific NADPH Oxidase 4 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific NADPH Oxidase 4 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America NADPH Oxidase 4 Sales Value (2021-2032)
  21. 6.9.2 South America NADPH Oxidase 4 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa NADPH Oxidase 4 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa NADPH Oxidase 4 Sales Value Share by Country, 2025 VS 2032
7 NADPH Oxidase 4 Country-level Sales and Value Analysis
  1. 7.1 Global NADPH Oxidase 4 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NADPH Oxidase 4 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global NADPH Oxidase 4 Sales by Country (2021-2032)
  4. 7.3.1 Global NADPH Oxidase 4 Sales by Country (2021-2026)
  5. 7.3.2 Global NADPH Oxidase 4 Sales by Country (2027-2032)
  6. 7.4 Global NADPH Oxidase 4 Sales Value by Country (2021-2032)
  7. 7.4.1 Global NADPH Oxidase 4 Sales Value by Country (2021-2026)
  8. 7.4.2 Global NADPH Oxidase 4 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt NADPH Oxidase 4 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt NADPH Oxidase 4 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt NADPH Oxidase 4 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bioasis Technologies Inc
  2. 8.1.1 Bioasis Technologies Inc Company Information
  3. 8.1.2 Bioasis Technologies Inc Business Overview
  4. 8.1.3 Bioasis Technologies Inc NADPH Oxidase 4 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bioasis Technologies Inc NADPH Oxidase 4 Product Portfolio
  6. 8.1.5 Bioasis Technologies Inc Recent Developments
  7. 8.2 GenKyoTex SA
  8. 8.2.1 GenKyoTex SA Company Information
  9. 8.2.2 GenKyoTex SA Business Overview
  10. 8.2.3 GenKyoTex SA NADPH Oxidase 4 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GenKyoTex SA NADPH Oxidase 4 Product Portfolio
  12. 8.2.5 GenKyoTex SA Recent Developments
  13. 8.3 Glucox Biotech AB
  14. 8.3.1 Glucox Biotech AB Company Information
  15. 8.3.2 Glucox Biotech AB Business Overview
  16. 8.3.3 Glucox Biotech AB NADPH Oxidase 4 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glucox Biotech AB NADPH Oxidase 4 Product Portfolio
  18. 8.3.5 Glucox Biotech AB Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NADPH Oxidase 4 Value Chain Analysis
  2. 9.1.1 NADPH Oxidase 4 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NADPH Oxidase 4 Sales Mode & Process
  6. 9.2 NADPH Oxidase 4 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NADPH Oxidase 4 Distributors
  9. 9.2.3 NADPH Oxidase 4 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst